Novo Holdings A/S - FREELINE THERAPEUTICS HLDGS ownership

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 17 filers reported holding FREELINE THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q4 2021$3,518,000
-46.5%
1,776,613
-7.9%
0.17%
-50.9%
Q3 2021$6,575,000
-65.8%
1,928,157
-18.3%
0.34%
-60.2%
Q2 2021$19,244,000
-33.7%
2,361,2290.0%0.85%
-28.8%
Q1 2021$29,043,000
-32.6%
2,361,2290.0%1.20%
-35.1%
Q4 2020$43,116,000
+315.3%
2,361,229
+255.1%
1.85%
+258.8%
Q3 2020$10,381,000665,0000.52%
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q2 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 1,361,064$24,853,0007.00%
Novo Holdings A/S 2,361,229$43,116,0001.85%
Ally Bridge Group (NY) LLC 425,000$7,761,0001.33%
TFG Asset Management GP Ltd 750,000$13,695,0000.92%
SECTORAL ASSET MANAGEMENT INC 657,494$12,006,0000.85%
FRAZIER MANAGEMENT LLC 550,000$10,043,0000.77%
Eventide Asset Management 2,485,656$44,266,0000.68%
Ovata Capital Management Ltd 14,981$274,0000.09%
AXA S.A. 551,476$10,070,0000.03%
Woodline Partners LP 25,932$474,0000.01%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders